Loading clinical trials...
Loading clinical trials...
Phase 2 Randomized Study of Carboplatin/Paclitaxel With or Without CS-7017 in Chemotherapy-Naïve Subjects With Metastatic Non-Small Cell Lung Cancer
Conditions
Interventions
CS7017 tablets
Paclitaxel
+2 more
Locations
28
United States
University Colorado Cancer Center
Aurora, Colorado, United States
Georgetown Univ. Medical Center
Washington D.C., District of Columbia, United States
Southern Illinois Hematology/Oncology
Centralia, Illinois, United States
Rush University Medical Center
Chicago, Illinois, United States
Michiana Hematology-Oncology
South Bend, Indiana, United States
Harbor View Cancer Center
Baltimore, Maryland, United States
Start Date
December 1, 2008
Primary Completion Date
January 1, 2012
Completion Date
August 1, 2012
Last Updated
May 13, 2020
NCT06996782
NCT06975293
NCT06343402
NCT06955988
NCT06512051
NCT06216301
Lead Sponsor
Daiichi Sankyo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions